Larry Ramer

Larry Ramer

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

With a 3.3 Forward P/E Ratio, Cleveland-Cliffs Is a Great Deal

Stimulus plans in the U.S. and Europe, along with continued strong demand for homes and cars, are a few trends that will boost CLF stock.

Stem Stock Is a Buy on Its Latest Pullback

Stem is set to benefit from very strong macro trends, making STEM stock extremely attractive at this point.

Ocugen Likely Can’t Get a Boost From the FDA Until 2023

It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.

GM Stock Is Tremendously Undervalued Amid Strong, Positive Drivers

GM's strong performance in the U.S. and China, along with its improving reputation in the U.S., are among the positive drivers of GM stock.

GameStop Is Still Overvalued Despite More Positive Catalysts

Netflix's entrance into the vide-game sector could help GameStop, but the valuation of GME stock is still far too high.

4 Undervalued EV Stocks That Smart Investors Should Buy Now

SOLO stock, ARVL stock, AYRO stock and XPEV stock are EV stocks that are trading far below their long-term potential.

Alibaba Stock Is Too Risky as China’s Crackdown Continues

Dictatorships often react very harshly to criticism, so BABA stock is very vulnerable after Jack Ma blasted Beijing last year.

You’d Be Wrong to Paint Bionano Genomics Stock With the Meme-Stock Brush

With Bionano's disruptive tool, Saphyr, poised to revolutionize the DNA analysis sector, investors should definitely look to buy BNGO stock on its recent dip.

Churchill Capital Corp IV Isn’t Just Overvalued, It’s Caught up in the Meme Stock Spiral

Given the risks facing CCIV stock and its huge valuation -- along with the retreat of the meme names -- the shares are likely to tumble for the foreseeable future.

Don’t Mistake SoFi As a Tech Disruptor

SoFi is not disruptive and primarily relies on lending to boost its bottom line. Therefore, the valuation of SOFI stock is far too high.